b p of pharm, aj-wk-09 - copy

Upload: angela

Post on 01-Mar-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    1/25

    Basic Principle

    of Pharmacology

    Pharmacology & Therapeutic Depart.

    School of Medicine

    Universitas Sumatera Utara

    Drs. Admar Jas M.Sc. Apt

    Senen !" #$t. %!!

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    2/25

    Topi$' Drug as a molecule

    oMen(elas$an definisi o)at s)g *igand

    oMen(elas$an peran chiral enantiomer danracemic.

    omen(elas$an )entu$ dan u$uran ligand +drug

    si,e & shape-.oonformation and chemistry of receptors and

    ligands +men(elas$an pengertian reseptor-.oDrug receptor )inding +men(elas$an i$atan o)at

    reseptor-'

    !. /an der 0aals

    %. 1ydrogen2. 3onic

    4. ovalent

    5. 1ydropho)ic

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    3/25

    36T7#DUT3#6 #8 P1A7MA#*#9:

    The study of substances that interact with livingsystems:

    1. Through chemical processes,

    2. Especially by binding to regulatory molecules in

    activating/ inhibiting normal body processes.

    Pem)eri $uliah' A. Jas & 0a$idi ; BB2;

    Blo$ Basic Biologi of ells TA %!=%!

    Kuliah: Rb. 01-9-10

    Pk. 10.00-11.00 Wib

    Pk. 14.00-15.00 Wib

    P1A7MA#*#9: D7U9S '

    ;Pharmaco$inetic > pharmacodymamic;1omeostatic

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    4/25

    Physical and chemistry properties of drugs

    Sifat fisika-kimia obatnasib obat di dalam tubuh

    kelarutannya di dalam tubuh membran sel, plasma darah!

    metabolisme biotransformasi!

    reaksi biologis reaksi biokimia " aktivitas farmakologi obat!

    Pharmaco$inetic +ADM?-Pharmacodynamic;)inding

    ;interaction @ith receptor or @ithouth receptor

    ;actions +activation = inhi)iton-

    Any su)stance that )rings a)out a change in )iologic

    function through its chemical action

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    5/25

    Solid (cystals/crystalli! "o#d!r$

    %i&uid

    'as!ous

    Asetosal paracetamol 6al

    Atropine efedrin

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    6/25

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    7/25

    hemistry

    0ea$ acid

    0ea$ )ase

    Ionization, esterification, hydrolisa, chelating

    complex, redox, colour altering.

    6ote'

    This is importan for a)sorption ;; molecule across mem)rans cell

    )y transport diffusion filtrasi vacuola etc.

    K!bayaka obat-obata b!rsiat as l!ah

    6i labu* tidak t!r3adi "!ruraia / ioisasi)

    aka udah larut dala l!ak da !l!#ati

    !bra s!l

    !r3adi "!ruraia / ioisasi dala

    labu*) obat aka b!rsiat "olar sh*

    obat sulit !l!#ati !bra s!l.

    #ydator

    7edu$torR!do, "!ti* dala ra*ka"!ruraia da "!rubaha b!tuk

    s!ya#

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    8/25

    D7U9 S3E?.

    Molecular si,e ' M0 " +lithium to over M0 5 +throm)olytic en,ymes-

    Molecular @eight ' ! >!

    The lo@er limit of this narro@ range is pro)a)ly set )y the reFuirements for

    spesificity of action.

    To achieve sach selective )inding it appears that a molecule should in most

    cases )e at least ! M0. The upper limit in molecular @eight is determinedprimarily )y the reFuirement that drug )e a)le to move @ithin the )ody.

    Drug larger than M0 ! @ill not diffuse readly )et@een compartement of the

    )ody. Therefore very large drugs +usually proteines- must )e administered

    directily into the compartement @here they have their effect.

    3n the case of alteplase a clor;dissolving en,yme the drug is administereddirectily into the vascular compartement )y intravenous infusion.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    9/25

    Drug;7eceptor

    May )e the Drug;receptor has )ind chemical sach as'

    !. /an der @aals

    %. 3$atan hydropho)

    2. 1ydrogen4. 3onic

    5. ovalen

    Ad. !. 3$atan /an der @aalsgaya yg ter(adi antara atom yg memp $emampuan polarisasi $md

    terindu$si asimetri$ dlm a@an ele$tron oleh inti yg )erde$atan leta$nya shg

    ter(adi tari$ menari$ antara dua atom. Dayanya )er$urang se)anding dg (ara$

    pang$at G ;;; !=7 G.

    Jara$ antara atom dimana gaya /an der 0aals masih ada ' 4;G nm.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    10/25

    Ad. 2. 3$atan 1ydrogenstabilitas itra struktur dala ol!kulya.

    7kata ii t!r3adi it!raksi !l!ktrostatik dari "asa*a !l!ktro suyi dari ato

    +) S) s!ba*ai door da ato 8 sb* aks!"tor (k!kura*a !l!ktro$)

    is: -S8 -+8 -8 8--8 d* sudut 104)5 o

    'aya ii akibat dari "olritas air ya* ti**i s!hi**a t!r3adi sudut ikata 104)5

    Ad. %. 3$atan hydropho) +seny non polar )erintera$si dg mol air-. 7kata atara ol o "olar (ba* hidrocarbo$ y* tidk a"u !b!tuk

    ikata hidro*! d* ol air) sh* ol air l!bih t!ratur l!takya d!kat ol!kul tsb

    !b!tuk "!rukaa atara diti*kat ol. is:

    -Ratai sa"i* l!usi dari "rot!i d!*a air. -S!ya#a ali;atis/ aroatis d!*a air

    -Stabilisasi koorasi "rot!i

    -ras"ort li"ida "ada "rot!i "lasa

    -P!*ikata st!roid "ada r!s!"tor

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    11/25

    Ad. 4. 3$atan 3onic

    7kata ya* t!r3adi atara uata io ya* b!rla#aa) it!raksi !l!ktrostatik sa*at kuat) !l!bihi k!kuata

    it!raksi "ada ikata ko;al!. is. : +a +a=l

    Ad. 5. 3$atan

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    12/25

    SB% KK) 15 +PR 0C (=D-K1 B.Eas-WK$

    EF6F%: BS7= PR7+=7P% G P8BRB=%'H

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    13/25

    3

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    14/25

    Pem)eri $uliah' Datten Bgn & A(as

    Jumat 2 = !!;G p$. H;!. 0i)

    Pharmacology molecular concept

    !. Drugs that do not fit the drug;receptor model

    %. 3npact of drug )inding on reseptor conformation

    2. Processing of signals resulting from drug;receptor interactions

    4. elluler regulation of drug;receptor interactions

    5. Moleculler and celluler determinants of drug selectivity

    Senya@a o)at atau senya@a )ioa$tif umumnya di$elompo$an men(adi % golongan a.l'

    !. Senya@a o)at = )ioa$tif )erstru$tur $has yaitu a$tivitasnya sangat tergantung pada

    stru$tur mole$ulnya.

    %. Senya@a o)at = )ioa$tif yang )erstru$tur tida$ $has yaitu a$tivitas )iologinya tida$

    tergantung pada stru$tur mole$ulnya.

    !ori k!r3a bat diti*kat ol!kul:Untu$ menerang$an )agaimana antara$si o)at dengan reseptor ada )e)erapa teori al'

    !. Pendudu$an reseptor +lar$ & 9addum-

    %. Ariens & Stephenson

    2. *a(u rea$si

    4. harniere

    5.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    15/25

    Ad. 3. Drugs that do not fit the drug;receptor model

    Bti;ity by ot r!c!"tor as !diat!d !chais. Structur! o s"!ciic dru*s ar! thos!

    i #hich th! "haracolo*ical actio is ot dir!ctly d!"!d!t o th! ch!ical structur!

    o th! dru*) !,c!"t that structur! !!cts "hysico-ch!ical "ro"!rti!s. Structural o

    s"!ciic dru*s act by "hysico-ch!ical "ross!s!ss.,a"l!s:

    -osotic diur!tics

    -atacids

    -ch!lati* a*!t

    -la,at (lubricat$

    -!oli!t

    Bd. 77. 3npact of drug )inding on receptor conformation

    1. h! si"l! actio or "roduc! a !!ct

    ,a"l!s: sy"athoi!tic ad "arasy"athoi!tic dru*s

    -adr!!r*ic

    -choli!r*ic

    The first massenger I 7 I 9;protein ;;;; M79 I effector ;;;; the second massenger @ill )e

    7eleased.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    16/25

    D. =ha*!s i r!c!"tor cooratio

    D.1. haci* th! aiity o th! dru* or th! r!c!"tor ------ iduc!t it

    r!c!"tor alt!ri* th! actio o th! r!c!"tor.

    ,a"l!s: isuli aalo* --- stiulat! all th! isuli r!c!"tor to th! sa! !,t!t

    d!s"it! sli*htly di!r!t aio acid s!&u!c!

    . Pr!;!ti* th! r!c!"tor to bid #ith its !do*!ous li*ad) #ithout cha*i* th!

    cooratio

    ,a"l!s: =urar!

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    17/25

    Transmem)rane 3on hannels

    9 P7#T?36 and Second Messenger

    3npact of drug )inding on receptor conformation

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    18/25

    2.%. 3nhi)iting ;;;;;; inactivation

    Ad. 333. Processing of signals resulting from drug;receptor interactions

    1. !ss!*!r : =at!cholai!s

    . !ss!*!r : c. BP ,. %1 < R -------> '- "rot!i ---------------> B =5 ------ c. BP

    % < R -------> '- "rot!i ---------------> B =i ----->?? c BP

    !. lar$ dan 9addum:

    7t!sitas !!k b!rbadi* la*su* d* 3l r!s!"tor ya* dit!"ati ol!h s!ya#a obat. Btaraksi obat-

    r!s!"tor

    s!suai d!*a huku aksi asa s!"!rti "!rsaaa ii:K1

    R < ----------------> R ---------->

    I--------------

    k

    El r!s!"tor y* dit!"ati obat t*t "ada kos!trasi obat "ada ko"art!! r!s!"tor da 3ul k!s!luruha

    r!s!"tor da !!k obat l!bih kuat bila 3l r!s!"tor y* dit!"ati s!aki bayak. !ori ii tidak da"at

    !3!laska ada obat t!rt!tu b!k!r3a sb* a*ois da obat lai d* struktur ya* saa b!k!r3a sb* ata*ois.

    %. Teori Ariens dan Stephenson

    Btaraksi obat d!*a r!s!"tor !caku" dua taha") yaitu

    a. P!b!tuka ko"l!ks obat-r!s!"tor

    b. !u3ukka !!k

    P!rsyarataya) a.l :

    1. S!ya#a obat harus "uya aiitas kuat thd r!s!"tor

    . Bkti;itas itriksikD. Struktur s"!siik

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    19/25

    R!c!"tor !diat!d acti;atio o a ' "rot!i ad

    th! R!sultat !ctor it!ractio

    a$ 7 th! r!sti* stat!) th! ad subuits o ' "rot!i ar! associat!d #ith o! aoth!r)ad '6P is boud to subuit.

    b$ idi* o a !,trac!llular li*ad (a*oist$ to a ' "rot!i-cou"l!d r!c!"tor !,cha*!o 'P or '6P o th! subuit.

    c$ h! subuit dissociat!s ro th! subuit) #hich dius!s to it!ract #ith !!ctor"rot!is. 7t!ractio o th! 'P-associat!d subuit #ith a !!ctor acti;at!s th!!!ctor.

    o 7 so! cas!s ) th! subuit ca also acti;at! !!ctor "rot!is.

    o 6!"!di* o th! r!c!"tor subty"! ad th! s"!siic 'isoor) 'ca also ihibit th! acti;ity o a !!ctorol!cul!.

    o h! subuit "oss!s!s itrisic 'Pas! acti;ity) #hich l!ads to hydrolysis o 'P to '6P. his l!ads tor!associatio o th! subuit #ith th! subuit ad th! cycl! ca b!*i a*ai.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    20/25

    Ad. 3/. elluler regulation of drug;receptor interactions

    6ru* ---- Gor!i* body to our c!lls) "risi"l! ho!ostatis

    !. 6o of receptors

    -u"r!*ulatio --b!ta-block!r

    -do# r!*ulatio --- =B (tricyclic acid$ --- atid!"r!ssat

    ,. "iat ------ tol!rasi

    %. Tachyphylais --- tol!rasi c!"at t!r3adi

    -r!duc! !!ct "roduc!d at!r r!"!at!d adiistratio

    2. Teori harniere

    Menerang$an mengapa suatu agonis mes$ipun td$ dapat menggeser antagonis dari resep

    tornya dapat )ersaing dg antagonis sesuai dengan hu$um a$si masa. 7eseptor mempunyai

    dua $edudu$an a. l'

    !.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    21/25

    4. 7acti;astio

    %oss o ability a r!c!"tor to r!s"od) to stiulatio by a dru*

    5. R!ractory

    Bt!r a r!c!"tor is stiulat!d) a "riod o ti! is r!&uir!d b!or! th! !,t dru*-r!c!"tor

    it!ractio ca "roduc! a !!ct.

    Ad. /. Moleculler and celluler determinants of drug selectivity

    6ru* 2 r!c!"tor it!ractios

    S"!ciicity : tissu!) syst!s) or*a #h!r! r!c!"tors ar! distribut!d (co"art!!t$

    ,. Bdr!!r*ic ad choli!r*ic

    S!l!cti;ity : dru* it!racts "r!!r!tially o "articular r!c!"tor ty"!s or sub ty"!s.,. Pro"aolol: o s!l!cti;! ---- ata*oist o !ad J

    Bt!olol : !2s!l!cti;!) %l!ss !rbutali : a*oist o %

    6!t!riat :

    h! ch!ical structur! ay b! ;!ry uch di!r!t) y!t th! "haracolo*ical actio ar!siilar.B sli*ht odiicatio i ch!ical structur!do!s ot "roduc! a draatic cha* i "haracolo*icalactio. Structural s"!ciic dru*s ar! thos! i #hich th! "haracolo*ical actio d!"!d!t dir!ctly

    o th! ch!ical structur! o th! dru*) #ichh attach!s its!l to a three;dimensionalstructur! o a

    r!s!"tor i th! bio"has!. Pr!r!&uisit!s o th! bidi* o a dru* to r!c!"tor ar!: ch!ical) r!acti;ity

    "r!s!c! o u*sioal *rou"s) !l!ctoic distributio ad to"o*ra"hic irror-lik! ia*! o th!

    r!c!"tor.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    22/25

    Stereoisomers

    8a;! th! sa! ol!cular orula ad th! sa! ord!ro attach!t o th!ir atos (th! sa! co!cti;ity$)

    but di!r!t thr!!-di!sioal ori!tatios o th!ir

    atos i s"ac!.

    2 !,a"l!: th! cis-tras iso!rs o cycloalka!s

    cis-1,4-Dimethyl- cyclohexane

    and

    H

    CH3

    CH3

    HCH3

    H

    CH3

    H

    trans-1,4-Dimeth cyclohexane

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    23/25

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    24/25

    6ru*s siilar "haracolo*ical actio ha;! usually so! coo structural caract!ristics

    #ith uctioal *rou"s i siilar s"atial dir!ctio. B sli*ht odiicatio i ch!ical

    structur! ay "roduc! draatic cha*! i "haracolo*ical actio (ro icr!s!d acti;ity

    to ata*ois.

    R!c!"tor ar! all s"!ciic ol!cul!s) ol!cul! co"l!,!s or "art o th!s!) #hich bid

    th! dru* ch!ically ad this co"l!, !,!rts a "haracolo*ical actio.

  • 7/25/2019 B P of Pharm, AJ-WK-09 - Copy

    25/25

    Kos!" Garakolo*i ol!kular

    bat adl Aat akti ya* sudah t!rbukti b!r*ua utuk "!uliha k!s!hata) tidak s!ua Aat akti da"at di*uaka

    s!ba*ai obat.

    Gokus: !kais! k!r3a obat-obat t!rutaa it!raksi obat d* r!s!"tor sh* t!r3adi suatu !!k.

    9am)ar' peru)ahan $onformasi suatu en,im yg diim)as oleh su)stratnya

    Pada *abar ii t!r3adi *aya ataraksi atara ratai "rot!i) ol!kul substrat da io-io ya* ada dala

    laruta dib!ri tada 8 utuk *aya hidroob < da 2 utuk *aya !l!ktrostatik. Ko"l!ks "rot!i-substrat

    ya* t!rb!tuk da"at b!rdissosiasi da "rot!i t!rli"at k!bali k! koorasi s!ula.

    bat diba*i dala k!lo"ok b!sar) yaitu:1. Struktur s"!siik) utk b!k!r3a !butuhka r!s!"tor --- "!rubaha "ada sist!!!ktor) ada !!k da

    da"at diaati.

    . Struktur o s"!siik) tidak butuh r!s!"tor ---- tidak ada !!k.

    is: Btacida) laksa osotik / *ara (*S4$) *lis!ri) +aD P4

    6iur!tik osotik